EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Hepatic Tumoral Calcinosis in a Patient With Obesity and Metabolic Syndrome: A Case Report

Tianshi Xiang, Fei Xie, Mengmeng Ji, Zheng Liu, Feng Jiang, Xiaoping Liu

Case Reports in Surgery · 2026-01 · 2026 (1)

DOI: 10.1155/cris/9210483 ↗
AbstractBibliografische Angaben

Abstract

Tumoral calcinosis is a kind of non‐tumour calcium salt deposition, is an extremely rare disease, is also a soft tissue rare non‐tumour lesion, belongs to the autosomal dominant genetic disease, mostly occurring in adolescents, seldom exceeding the age of 50 years, with a similar proportion of men and women, and its tumoral calcinosis occurs in the bone and joint parts, especially located in the femur rotator cuff, the elbow, the lateral part of the shoulder and the hip parts, which is manifested as it is characterised by painless subcutaneous calcified masses around the joints, which slowly increase in size, with a history of up to several years, and generally without obvious clinical symptoms. Therefore, this disease usually occurs in the bone and joints, and less frequently in the parenchymal organs. In this paper, we present a case of tumoral calcinosis in the liver, in which the patient was found to have a 24‐year‐old male presented with a 9‐day history of a space‐occupying lesion in the left lateral segment of the liver adjacent to the gastric curvature, accompanied by vague abdominal pain on satiety, without nausea, vomiting, chills, fever, or jaundice. Imaging features, laboratory tests and pathological findings confirmed our diagnosis, and a good outcome was achieved by surgical resection of tumoral calcinosis in the liver.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →